In pharmaceutical manufacturing, every tablet and capsule represents a commitment to quality, patient safety, and regulatory compliance. Even minor product defects can lead to costly recalls, production downtime, regulatory scrutiny, and damage to a manufacturer’s reputation.

As production speeds continue to increase and quality standards become more stringent, pharmaceutical manufacturers need inspection technologies that identify defects before products leave the facility. Modern X-ray inspection systems play a critical role in ensuring only compliant products reach patients.

Common Defects in Tablet and Capsule Production

Solid dose manufacturing involves numerous processing steps, including blending, compression, encapsulation, coating, and packaging. Throughout production, several types of defects can occur that may compromise product quality.
Common issues include:

• Broken or chipped tablets
• Cracked or split capsules
• Missing tablets or capsules within blister packs
• Double-filled blister cavities
• Foreign material contamination
• Product fragments
• Incorrect product counts
• Damaged packaging that affects product integrity

While some defects are visible during manual inspection, many become difficult or impossible to detect at high production speeds. Automated inspection systems provide consistent inspection performance without operator fatigue or variability.

Why X-Ray Inspection Is Ideal for Pharmaceutical Tablets and Capsules

Unlike traditional inspection methods that rely solely on visual appearance, X-ray inspection analyzes product density. This allows manufacturers to detect a wide range of product and packaging defects, even when products are enclosed in foil blister packs or opaque packaging.

Modern pharmaceutical X-ray systems can inspect:

• Tablets in blister packs
• Capsules in blister packs
• Bottled pharmaceuticals
• Cartoned products
• Bulk pharmaceutical products

In addition to detecting foreign material contamination, X-ray inspection can verify product presence, identify broken tablets, detect empty blister cavities, and confirm proper product counts during production.

Because inspection occurs inline, defective products can be automatically rejected before they continue downstream, minimizing waste while protecting product quality.

Quality Control Best Practices for Solid Dose Manufacturing

Successful pharmaceutical inspection programs combine advanced technology with well-defined quality procedures.

Manufacturers should consider the following best practices:

Inspect Early and Throughout Production

Rather than relying solely on final package inspection, implementing inspection at multiple stages helps identify process issues before they affect large production batches.

Validate Inspection Performance

Routine validation ensures inspection systems continue meeting internal quality standards and regulatory requirements. Scheduled performance verification also provides documented evidence for audits.

Automate Product Rejection

Inspection is only effective when defective products are consistently removed from production. Automated reject devices eliminate reliance on manual sorting while improving traceability.

Collect Inspection Data

Inspection systems that record production data provide valuable insights into recurring quality issues. Manufacturers can identify trends, optimize processes, and support continuous improvement initiatives.

Integrate Inspection into Overall Quality Programs

Inspection technology should complement existing GMP procedures, risk management programs, and quality management systems to create a comprehensive approach to pharmaceutical manufacturing.

Preventing Recalls Through Early Defect Detection

Product recalls can result in significant financial losses while impacting customer confidence and regulatory standing. Many recalls originate from manufacturing defects that could have been identified before products reached distribution.

By implementing reliable inline inspection, pharmaceutical manufacturers can:

• Detect defects before products are packaged and shipped
• Reduce customer complaints
• Minimize costly recalls
• Improve production consistency
• Support regulatory compliance
• Protect patients and brand reputation

Early detection also reduces unnecessary waste by identifying process issues before they affect larger production runs.

How Anritsu Supports Pharmaceutical Quality Assurance

Anritsu’s pharmaceutical inspection solutions are designed to help manufacturers achieve high levels of product quality while maintaining production efficiency. Advanced X-ray inspection systems deliver reliable detection of missing, broken, or damaged tablets and capsules, as well as foreign material contamination across a variety of pharmaceutical packaging formats.

Combined with intelligent inspection software, automated rejection systems, and comprehensive data collection capabilities, Anritsu helps pharmaceutical manufacturers strengthen quality assurance programs, support regulatory compliance, and reduce operational risk.

Whether inspecting blister packs, bottles, cartons, or other solid dose packaging, Anritsu solutions provide the consistent inspection performance required for today’s pharmaceutical production environments.

Build Confidence in Every Package

Detecting defects before products leave the production line protects more than product quality. It protects patients, brands, and long-term business success.

As pharmaceutical manufacturers continue to automate production and increase throughput, advanced X-ray inspection remains an essential component of a modern quality assurance strategy.

By identifying defects early in the production process, manufacturers can improve operational efficiency, reduce waste, strengthen compliance efforts, and deliver safe, high-quality products to market with confidence.

Learn more about Anritsu’s pharmaceutical inspection solutions and discover how advanced X-ray inspection technology can help improve product quality, support regulatory compliance, and protect your brand.